What are you looking for? Write the name, title or any keyword related to what you are looking for and select which content category it belongs to. Search Fulltext search Activities Professionals Research groups News - Any - News Vall d'Hebron researchers present new strategies for preventing infections at ICU The ICU team at Hospital Vall d'Hebron and the research group of severe sepsis and respiratory infection in its Research Institute (VHIR), coordinated by Dr. Jordi Rello, have presented important developments at the Congress of the European Society of Intensive Care (ESICM), that has taken place the News VHIR supports CAIBER project Instituto de Salud Carlos III promoted since 2008 the project of Consortium to Support Biomedical Research Network (CAIBER) as a platform for clinical trials. CAIBER has already included forty of the more powerful and competitive health centers of the country, establishing frameworks for cooperation News EATRIS presents its infrastructure concept in Rome The EATRIS Conference “From Basic Research to Medical Innovation”, held in Rome 7-8 October, served to present the infrastructure concept of this program launched by the European Commission to support infrastructures for the biomedical sciences. After three years of frequent exchange and intense w News The health computerization project between VHIR and Ilimit receive an ACC1Ó grant The Catalonian company specialized in technology -Ilimint- has achieved an ACC1Ó grant to carry out together with the Institut de Recerca Hospital Universitari Vall d'Hebron in Barcelona (VHIR ) the R & D related to Information Technology (IT) applied to the health sector. This grant, which receives News Dr. Cabero reflections about 2010 Medicine Nobel Prize Dr. Luis Cabero, responsible for Maternal and Fetal Medicine at Vall d'Hebron Research Institute, expresses his views on the 2010 Medicine Nobel Prize for Robert G. Edwards, 'father' of fertilization in vitro. "It is a great tribute to Edwards work, that not only advances in conception, but also op News Identified one of the reasons for the neuronal death of patients with Parkinson Researchers from Vall d'Hebron Research Institute (VHIR) present the results of a study that explains how the presence of some abnormal clumps of proteins inside nerve cells is associated with neuronal death in Parkinson's patients. This research also raises, at an experimental level, a new therapeu News Low MBL level increases risk of subclinical graft rejection Trying to identify early the group of patients at increased risk of subclinical rejection of the graft is one of the challenges to improve outcomes after transplantation, hence useful predictors markers are sought. The MBL (Mannose Binding Lectin) protein has emerged as one of these biomarkers, suc News Dr. Morell at ERS The director of the Pneumology service at Hospital Vall d’Hebron, doctor Ferran Morell, took part with an oral presentation on the Congress of the European Respiratory Society (ERS), in Barcelona, from 18 to 22 September. "http://www.itbeganhere.com/firabcn/firanews/EN/smoking.html" More informati News VHIR's researchers develop a test to detect prostate cancer VHIR's researchers Marina Rigau, Andreas Doll and Jaume Reventós, together with Dr. Joan Morote, responsible of the Urology Service, have developed a test to improve the early detection of prostate cancer from an urine analysis. The test has determined in approximately two hundred men who came to t News Identified the genes responsible of the incomes for intensive care patients with A flu A research team from Vall d'Hebron Research Institute (VHIR) have studied the immunological answer in the patients who required income to Intensive Cares for severe pneumonia during the acute phase of the A flu. The conclusions of the study indicate that, in those most severe cases, the failure of t News Catalonian Health Minister opens Collserola Building, VHIR's new facilities Catalonian Health Minister, Marina Geli, opened on Wednesday 22 September the new facilities of Vall d'Hebron Research Institute (VHIR), Building Collserola. Building Collserola, made with the support of P.O. FEDER2007-2013, will host nearly 200 scientists in its 2500 m2, and complements the Medit News Stopping antiplatelet therapy after a drug active stent placement increases high risk of thrombosis Researchers from Vall d'Hebron Research Institute (VHIR) lead a study showing epidemiological data on the causes and consequences of noncompliance with antiplatelet therapy with platelet after placement of a drug-eluting stent or drug active stent. Due to the severity of the effects of stopping t News Alicia Koplowitz Foundation provides significant funds to a project coordinated by Dr. Comabella A project coordinated by Dr. Manuel Comabella, member of the Neuroimmunologia Group at Vall d'Hebron Research Institute (VHIR), in which also participates Rana Moubarak, a member of Cell Signaling and apoptosis research group, has received a substantial fund from the Alicia Koplowitz Foundation. T News Discovered new markers of risk and response to treatment in ictus The Neurvascular Laboratory of Vall d'Hebron Research Institute (VHIR) found some genetic variants that, on the one hand, represent an indicator of response to treatment in ictus as a marker and, secondly, is associated with increased risk for this disease. These results are the fruit of a long his News The scientific perspective on intersexuality Dr. Laura Audi, member of the Endicronology Paediatric Unit at Vall d'Hebron Research Institute (VHIR) gives her views on intersexuality. Years ago, it was assigned one sex to the baby that eventually, could be wrong. Now, thanks to advances in genetic, morphological and hormonal studies, is possib News A study explores the relationship between personality patterns and the different subtypes of ADHD Researchers from Vall d'Hebron Research Institute (VHIR) have established clear relationships between different personality patterns of patients with Attention Deficit Disorder and Hyperactivity Disorder (ADHD) and disorder subtypes that these patients suffer. The results of this study, published News New expectations for the treatment of metabolic diseases Researchers from Vall d'Hebron Research Institute (VHIR) lead an unprecedented study that shows that it is possible to modify the composition of the intestinal flora transplanting it, and that generated changes remain, beyond expectations, up to three months after transplantation. The ability to v News VHIR stands out in an h index ranking Researchers of Vall Hebron Institute de Recerca (VHIR) occupy a prominent position in a ranking that publishes a list of the best Spanish researchers according the h index. It consists on a method that evaluates the impact of scientific research in different areas of knowledge. According to the stud News End of Pandemic Influenza A: Reviews of Dr. Rello As coordinator of the European Registry of severe cases of A influenza, Dr. Rello, Head of Research Group on sepsis and severe respiratory infection of VHIR, summarizes the management of the first pandemic of the XXI century in the tv show 'Els Matins', of TV3. News Dr. Montalban opinion about Salvitex on the market Chief of Clinical Neuroimmunology at Vall d'Hebron Research Institute (VHIR), Dr. Xavier Montalban, talks about the green light from the health authorities to market Sativex in Spain, a drug derived from cannabis for the treatment of spasticity in multiple sclerosis patients. Pagination First page « Previous page ‹ … Page 151 Page 152 Current page 153 Page 154 Page 155 … Next page › Last page »
